Bone Morphogenetic Proteins Market Analysis | 2021-2026

“The Bone Morphogenetic Proteins market is projected to grow from USD 542.3 million in 2020 to USD 633.1 million by 2026 at a CAGR of over 2.6% during the forecast period”.

Market Dynamics

Introduction

Bone morphogenetic proteins (BMPs) are signaling molecules and most of them are a part of the Transforming Growth Factor-β (TGFβ) family of proteins. These proteins have a key role in bone and cartilage formation and embryogenesis. Bone morphogenetics further plays a major role in the development of the central nervous system.

Market Drivers

The rising number of people suffering from spinal injuries along with a surge in surgical rates are expected to boost the industry growth in the coming years. Also, ongoing research undertaken by different manufacturing companies for discovering the therapeutic potential of BMP in various orthopedic disorders, including soft tissue repair and osteoarthritis, is likely to bolster the product demand.

In addition, the growing number of spinal injuries, sedentary lifestyle, sport-related injuries, and bad posture, further drive the market growth during the forecast timeline.

COVID-19 Impact

The COVID-19 pandemic has moderately affected the bone morphogenetic proteins industry. The rapid spread of COVID-19 has led to several thousands of hospital admissions. The focus of healthcare professionals has been shifted toward the treatment of COVID-19-infected patients, which affected the treatment of non-emergency medical conditions, amid the pandemic.

Segments Analysis

By Application Type

“Spinal Fusion held the largest market share in 2020 and is likely to grow at a considered CAGR during the forecast period”.

The market has been segmented into spinal fusion, trauma, reconstructive surgery, and oral-maxillofacial. Under these, spinal fusion held the largest market share in 2020 and is likely to grow at a considered CAGR during the forecast period.

Degenerative disc disorder of the spine is mainly due to accidental falls, sports injuries, or osteoporosis in the aging population. Also, the presence of favorable reimbursement policies for spine infusion procedures further bolsters the segment growth.

Regional Analysis

“North America held a significant market share in 2020 and is projected to grow at a healthy CAGR during the forecast period”.

The market is broken down geographically into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In terms of regions, North America held a significant market share in 2020 and is projected to grow at a healthy CAGR in the coming years.

Rising healthcare expenditure, growing awareness regarding minimally invasive BMP procedures, strong adoption of advanced technology by orthopedic surgeons, well-established healthcare infrastructure, and favorable reimbursement structure, augment the regional market growth during the forecast timeline.

Key Players

The following are the key players in the Bone Morphogenetic Proteins Market (arranged alphabetically)

• Bio-Techne (R&D Systems, Inc.) (US)
• Ember Therapeutics Inc. (US)
• Integra Lifesciences Holdings Corporation (US)
• Johnson & Johnson (US)
• Medtronic PLC (Ireland)
• Merck KGaA (Germany)
• Pfizer, Inc. (US)
• Stryker Corporation (US)
• Thermo Fischer Scientific (US)
• Zimmer Biomet Holdings, Inc. (US)

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research:

Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.